Aurisco Pharmaceutical Co.,Ltd.(XSSC:605116) added to S&P Global BMI Index
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.62 CNY | -2.19% | +1.95% | -4.65% |
Jun. 25 | Aurisco Pharmaceutical Gets Approval for Convertible Bond Sale | MT |
Apr. 28 | Aurisco Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.65% | 1.41B | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- 605116 Stock
- News Aurisco Pharmaceutical Co.,Ltd.
- Aurisco Pharmaceutical Co.,Ltd.(XSSC: 605116) added to S&P Global BMI Index